Real-world virological efficacy and safety of elbasvir and grazoprevir in patients with chronic hepatitis C virus genotype 1 infection in Japan

被引：0
作者：
Hidenori Toyoda
Masanori Atsukawa
Koichi Takaguchi
Tomonori Senoh
Kojiro Michitaka
Atsushi Hiraoka
Shinichi Fujioka
Chisa Kondo
Tomomi Okubo
Haruki Uojima
Toshifumi Tada
Hirohito Yoneyama
Tsunamasa Watanabe
Toru Asano
Toru Ishikawa
Hideyuki Tamai
Hiroshi Abe
Keizo Kato
Kunihiko Tsuji
Chikara Ogawa
Noritomo Shimada
Etsuko Iio
Akihiro Deguchi
Ei Itobayashi
Shigeru Mikami
Akio Moriya
Hironao Okubo
Joji Tani
Akihito Tsubota
Yasuhito Tanaka
Tsutomu Masaki
Katsuhiko Iwakiri
Takashi Kumada
机构：
[1] Ogaki Municipal Hospital,Department of Gastroenterology
[2] Nippon Medical School,Division of Gastroenterology and Hepatology, Department of Internal Medicine
[3] Kagawa Prefectural Central Hospital,Department of Hepatology
[4] Ehime Prefectural Central Hospital,Gastroenterology Center
[5] Okayama Saiseikai General Hospital,Department of Gastroenterology
[6] Nippon Medical School Chiba Hokusoh Hospital,Division of Gastroenterology, Department of Internal Medicine
[7] Kitasato University School of Medicine,Department of Gastroenterology, Internal Medicine
[8] Kagawa University School of Medicine,Department of Gastroenterology and Neurology
[9] St. Marianna University School of Medicine,Department of Internal Medicine
[10] Tokyo Metropolitan Bokutoh Hospital,Division of Gastroenterology and Hepatology, Department of Internal Medicine
[11] Saiseikai Niigata Daini Hospital,Department of Hepatology
[12] Wakayama Rosai Hospital,Department of Hepatology
[13] Shinmatusdo Central General Hospital,Division of Gastroenterology and Hepatology, Department of Internal Medicine
[14] Teine Keijinkai Hospital,Center of Gastroenterology
[15] Takamatsu Red Cross Hospital,Department of Gastroenterology and Hepatology
[16] Otakanomori Hospital,Division of Gastroenterology and Hepatology, Department of Internal Medicine
[17] Nagoya City University,Department of Virology and Liver Unit, Graduate School of Medical Sciences
[18] Kagawa Rosai Hospital,Department of Gastroenterology
[19] Asahi General Hospital,Department of Gastroenterology
[20] Kikkoman General Hospital,Division of Gastroenterology, Department of Internal Medicine
[21] Mitoyo General Hospital,Department of Gastroenterology
[22] Juntendo University Nerima Hospital,Department of Gastroenterology
[23] Yashima General Hospital,Department of Internal Medicine
[24] The Jikei University School of Medicine,Core Research Facilities for Basic Science
来源：
Journal of Gastroenterology | 2018年 / 53卷
关键词：
Chronic hepatitis C; Genotype 1; Elbasvir; Grazoprevir; Efficacy; Safety; Real world;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1276 / 1284
页数：8
相关论文
共 117 条
[1]  
Bennett H(2015)A review of the burden of hepatitis C virus infection in China, Japan, South Korea and Taiwan Hepatol Int 9 378-390
[2]  
Waser N(1997)Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy Ann Intern Med 127 875-881
[3]  
Johnson K(1997)Relationship between biochemical, virological, and histological response during interferon treatment of chronic hepatitis C Hepatology 26 780-785
[4]  
Marcellin P(2000)Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy Ann Intern Med 132 517-524
[5]  
Boyer N(1999)Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: a long-term observation study of 1643 patients using statistical bias correction with proportional hazard analysis Hepatology 29 1124-1130
[6]  
Gervais A(1998)Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C Ann Intern Med 129 94-99
[7]  
Shiffman ML(1999)Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan Ann Intern Med 131 174-181
[8]  
Hofmann CM(1998)Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C Hepatology 27 1394-1402
[9]  
Thompson EB(2013)Efficacy of pegylated interferon alpha-2b and ribavirin treatment on the risk of hepatocellular carcinoma of patients with chronic hepatitis C: a prospective multicenter study J Hepatol 58 495-501
[10]  
Shiratori Y(2012)Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis JAMA 308 2584-2593
12345678910